Skip to Content

GMO Emerging Country Debt IV GMDFX Fund Analysis

| Medalist Rating as of | See GMO Investment Hub

Morningstar’s Analysis GMDFX

Will GMDFX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

GMO Emerging Country Debt IV’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor